12/24
08:02 am
eols
Evolus (NASDAQ:EOLS) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Medium
Report
Evolus (NASDAQ:EOLS) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
12/19
07:08 pm
eols
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 [Yahoo! Finance]
Low
Report
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 [Yahoo! Finance]
12/1
09:02 pm
eols
Evolus (NASDAQ:EOLS) was given a new $19.00 price target on by analysts at Mizuho.
Medium
Report
Evolus (NASDAQ:EOLS) was given a new $19.00 price target on by analysts at Mizuho.
11/27
08:01 am
eols
Evolus, Inc.'s (NASDAQ:EOLS) Path To Profitability [Yahoo! Finance]
Low
Report
Evolus, Inc.'s (NASDAQ:EOLS) Path To Profitability [Yahoo! Finance]
11/19
02:55 pm
eols
The Dr. Randi Show Podcast, Sponsored by NewBeauty, Ranks in the Top 10% Globally for Conversations in Aesthetics, Beauty, Wellness & Medicine [Yahoo! Finance]
Low
Report
The Dr. Randi Show Podcast, Sponsored by NewBeauty, Ranks in the Top 10% Globally for Conversations in Aesthetics, Beauty, Wellness & Medicine [Yahoo! Finance]
11/14
04:05 pm
eols
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/12
10:05 am
eols
Moxie Announces Aesthetic Business Advisory Board and Scale Society Community to Shape the Next Era of Aesthetic Medicine
Low
Report
Moxie Announces Aesthetic Business Advisory Board and Scale Society Community to Shape the Next Era of Aesthetic Medicine
11/8
04:18 pm
eols
Evolus, Inc. (EOLS) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Evolus, Inc. (EOLS) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/6
10:22 am
eols
Evolus (EOLS) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
Neutral
Report
Evolus (EOLS) Q3 2025 Earnings Call Transcript [Yahoo! Finance]
11/5
04:05 pm
eols
Evolus Reports Third Quarter 2025 Financial Results
Medium
Report
Evolus Reports Third Quarter 2025 Financial Results
10/28
08:00 am
eols
Evolus to Participate in 2025 Stifel Healthcare Conference
Low
Report
Evolus to Participate in 2025 Stifel Healthcare Conference
10/22
08:00 am
eols
Evolus to Report Third Quarter Financial Results on November 5, 2025
Low
Report
Evolus to Report Third Quarter Financial Results on November 5, 2025
10/14
12:13 pm
eols
Evolus (NASDAQ:EOLS) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Evolus (NASDAQ:EOLS) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/10
04:49 pm
eols
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Low
Report
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
10/10
04:05 pm
eols
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/8
09:18 am
eols
Exfluential Wins "Best Enterprise or B2B Technology Innovation" at Octane's 2025 High Tech Awards [Yahoo! Finance]
Low
Report
Exfluential Wins "Best Enterprise or B2B Technology Innovation" at Octane's 2025 High Tech Awards [Yahoo! Finance]
10/1
08:30 am
eols
AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19 [Yahoo! Finance]
Low
Report
AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19 [Yahoo! Finance]